市場調查報告書
商品編碼
1503382
到 2030 年遠距病患監護市場預測 - 按產品(穿戴式裝置、行動裝置、遠距醫療、遠距監護裝置和其他產品)、服務、應用、最終用戶和地理位置進行全球分析Remote Patient Monitoring Market Forecasts to 2030 - Global Analysis By Product (Wearable Devices, Mobile Devices, Telehealth, Remote Monitoring Devices and Other Products), Service, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球遠距病患監護市場規模為 725.2 億美元,預計到 2030 年將達到 2,105.6 億美元,預測期內複合年成長率為 25.6%。遠端患者監測是一種醫療保健技術,可讓醫療專業人員在傳統臨床環境之外監測患者。它利用數位設備即時收集患者的醫療資料,例如生命徵象、症狀和其他健康指標。這些資訊被安全地傳輸給醫療保健提供者,從而在必要時實現持續監控和主動干預。 RPM 透過促進健康問題的早期發現、提高治療依從性和減少頻繁去醫院的需要來增強病患照護。
根據美國疾病管制與預防中心 (CDC) 的數據,美國有超過 1 億人患有高血壓,美國心臟協會 (AHA) 支持旨在增加遠距患者監測技術 (RPM) 使用範圍的舉措,以改善健康狀況管理。
慢性病盛行率增加
全球糖尿病、心血管疾病和呼吸系統疾病等慢性病的盛行率不斷上升,對傳統醫療保健環境之外的持續監測和管理提出了更大的需求,從而推動了遠端患者監測(RPM) 的成長。 RPM 可遠端即時監測生命徵象、症狀和健康參數,及早發現惡化的健康狀況並及時介入。這種積極主動的方法不僅可以改善患者的治療效果,還可以降低與可預防的住院和急診室就診相關的醫療費用,使 RPM 成為慢性病管理策略的重要工具。
有限的報銷政策
遠端病患監測 (RPM) 中有限的報銷政策通常源於建立標準化報銷框架的挑戰,該框架考慮了可用的各種 RPM 服務和技術。這些政策在不同地區和付款人之間存在很大差異,導致 RPM 服務覆蓋範圍存在不確定性和不一致。缺乏明確和全面的報銷可能會阻礙醫療保健提供者和組織投資 RPM 解決方案,從而減緩市場採用和創新。
老年人口不斷增加
隨著老年人口的增加,慢性病和與年齡相關的健康問題的盛行率也在增加,需要持續監測和管理。 RPM 技術使醫療保健提供者能夠遠端監控生命徵象、用藥依從性和整體健康狀況,從而促進早期干預和個人化護理。這種能力不僅可以改善老年人的健康狀況,還可以透過減少頻繁就診和住院的需要來提高他們的生活品質,從而有效且經濟高效地應對人口老齡化的挑戰。
技術壁壘
遠端病患監護的技術障礙包括不同設備和系統之間的連接性、互通性以及確保資料安全和隱私問題。這些障礙會阻礙無縫資料傳輸和即時監控,影響 RPM 解決方案的可靠性和有效性。此外,新技術的使用者接受度和可用性問題可能會降低醫療保健提供者和患者的採用率。
Covid-19 影響
由於醫療保健提供者力求最大限度地減少親自就診並降低暴露風險,Covid-19 大流行極大地推動了遠距患者監測市場。 RPM 的採用率激增,因為它能夠遠端監控 COVID-19 患者的生命跡象和症狀。這增加了對 RPM 解決方案的需求,推動了市場成長和創新。它還強調了 RPM 在危機期間管理醫療保健服務方面的潛力,從而擴大了大流行病之外的應用範圍。
預計穿戴式裝置市場在預測期內將是最大的市場
穿戴式裝置領域預計將出現利潤豐厚的成長。穿戴式裝置透過持續追蹤心率、血壓和活動水平等生命徵象,在遠端患者監測中發揮關鍵作用。它們使醫療保健提供者能夠即時遠端監控患者的健康狀況,及早發現異常情況,並在必要時及時進行干預。這些設備透過提供數據驅動的健康趨勢洞察並促進個人化治療計劃來增強患者護理,最終改善結果並降低醫療成本。
慢性病管理服務領域預計在預測期內複合年成長率最高
預計慢性病管理服務領域在預測期內將出現最快的複合年成長率。遠端患者監測涉及從遠處持續追蹤患者的健康資料,從而增強主動護理。這種方法利用穿戴式裝置和行動應用程式等數位技術來遠端監測生命徵象和症狀。醫療保健提供者可以及早期干預,減少住院並改善患者的治療結果。這是現代醫療保健中一種很有前景的策略,可以有效管理糖尿病、高血壓和心臟病等疾病。
在亞太地區,由於醫療保健支出增加、慢性病盛行率上升以及醫療保健技術進步,遠距病患監護市場正在經歷大幅成長。由於老年人口數量不斷增加以及對高效醫療保健管理的需求,日本、中國、印度和澳洲等國家正在大量採用 RPM 解決方案。政府推廣數位健康解決方案的措施進一步推動市場擴張。隨著持續的技術進步和醫療改革,亞太地區的市場有望持續成長。
在北美,遠距患者監護市場強勁且迅速擴張。由於先進的醫療基礎設施、有利的報銷政策以及糖尿病和心血管疾病等慢性病的高盛行率,該地區在 RPM 採用方面處於全球領先地位。在醫療保健成本增加和轉向基於價值的護理模式的推動下,美國和加拿大是市場成長的主要貢獻者。該市場的特點是創新,技術和監管框架的不斷發展支持其成長。
2024 年 1 月,班加羅爾著名的多專科醫院 Apollo Hospital 宣布與領先的人工智慧健康監測技術公司 LifeSigns 建立開創性合作夥伴關係。標誌著精準醫療和主動病患管理的重大進步。
2023 年 5 月,飛利浦推出了虛擬護理管理,這是一個由靈活的解決方案和服務組成的綜合產品組合,為醫療系統、提供者、付款人和雇主提供激勵,並與任何地方的患者互動。
According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $72.52 billion in 2024 and is expected to reach $210.56 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Remote patient monitoring is a healthcare technology that allows medical professionals to monitor patients outside of conventional clinical settings. It utilizes digital devices to collect medical data, such as vital signs, symptoms, and other health indicators, from patients in real-time. This information is transmitted securely to healthcare providers, enabling continuous monitoring and proactive intervention when necessary. RPM enhances patient care by facilitating early detection of health issues, improving treatment adherence, and reducing the need for frequent hospital visits.
According to the Centers for Disease Control and Prevention (CDC), over 100 million people have hypertension in the United States and The American Heart Association (AHA) supports initiatives that increase access to the use of Remote Patient Monitoring technologies (RPM) for better health management.
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases globally, such as diabetes, cardiovascular diseases, and respiratory conditions, drives the growth of the remote patient monitoring (RPM) by creating a greater demand for continuous monitoring and management outside traditional healthcare settings. RPM allows for real-time monitoring of vital signs, symptoms, and health parameters remotely, enabling early detection of deteriorating health conditions and timely intervention. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with preventable hospitalizations and emergency room visits, making RPM an essential tool in chronic disease management strategies.
Limited reimbursement policies
Limited reimbursement policies in remote patient monitoring (RPM) often stem from challenges in establishing standardized reimbursement frameworks that account for the diverse RPM services and technologies available. These policies vary widely across regions and payers, leading to uncertainty and inconsistency in coverage for RPM services. This lack of clear and comprehensive reimbursement can deter healthcare providers and organizations from investing in RPM solutions, slowing market adoption and innovation.
Growing elderly population
As the elderly population increases, so does the prevalence of chronic conditions and age-related health issues requiring continuous monitoring and management. RPM technology allows healthcare providers to remotely monitor vital signs, medication adherence, and overall health status, facilitating early intervention and personalized care. This capability not only improves health outcomes for seniors but also enhances their quality of life by reducing the need for frequent clinic visits and hospitalizations, thereby addressing the challenges of aging populations efficiently and cost-effectively.
Technological barriers
Technological barriers in remote patient monitoring include issues with connectivity, interoperability between different devices and systems, and ensuring data security and privacy. These barriers can hinder seamless data transmission and real-time monitoring, impacting the reliability and effectiveness of RPM solutions. Moreover, user acceptance and usability issues with new technologies can slow adoption rates among healthcare providers and patients alike.
Covid-19 Impact
The covid-19 pandemic significantly boosted the remote patient monitoring market as healthcare providers sought to minimize in-person visits and reduce exposure risks. RPM adoption surged due to its ability to remotely monitor COVID-19 patients' vital signs and symptoms. This increased demand for RPM solutions, driving market growth and innovation. It also highlighted RPM's potential in managing healthcare delivery during crises, leading to expanded applications beyond the pandemic.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in remote patient monitoring by continuously tracking vital signs like heart rate, blood pressure, and activity levels. They enable healthcare providers to remotely monitor patients' health in real-time, detect anomalies early, and intervene promptly when necessary. These devices enhance patient care by providing data-driven insights into health trends and facilitating personalized treatment plans, ultimately improving outcomes and reducing healthcare costs.
The chronic disease management services segment is expected to have the highest CAGR during the forecast period
The chronic disease management services segment is anticipated to witness the fastest CAGR growth during the forecast period. Remote patient monitoring involves continuous tracking of patients' health data from a distance, enhancing proactive care. This approach utilizes digital technologies like wearable devices and mobile apps to monitor vital signs and symptoms remotely. Healthcare providers can intervene early, reducing hospitalizations and improving patient outcomes. It's a promising strategy in modern healthcare for managing conditions such as diabetes, hypertension, and heart disease efficiently.
In the Asia Pacific region, the remote patient monitoring market is experiencing substantial growth driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in healthcare technology. Countries like Japan, China, India, and Australia are witnessing significant adoption of RPM solutions due to expanding elderly populations and the need for efficient healthcare management. Government initiatives promoting digital health solutions further propel market expansion. The market in Asia Pacific is poised for continued growth with ongoing technological advancements and healthcare reforms.
In North America, the remote patient monitoring market is robust and rapidly expanding. The region leads globally in RPM adoption due to advanced healthcare infrastructure, favourable reimbursement policies, and a high prevalence of chronic diseases such as diabetes and cardiovascular conditions. The United States and Canada are key contributors to market growth, driven by increasing healthcare costs and the shift towards value-based care models. The market is characterized by innovation, with ongoing developments in technology and regulatory frameworks supporting its growth.
Key players in the market
Some of the key players profiled in the Remote Patient Monitoring Market include Philips Healthcare, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Apollo, Omron Healthcare, GE Healthcare, Honeywell Life Care Solutions, Biotricity Inc., iRhythm Technologies, Smiths Medical, Resideo Life Care Solutions, Masimo Corporation, Qualcomm Life and Garmin Health.
In January 2024, Apollo Hospital, a renowned multi-specialty hospital in Bangalore, announces a pioneering partnership with LifeSigns, a leading AI-powered health monitoring technology company.This collaboration empowers the hospital with a cutting-edge 24/7 wireless and remote patient monitoring system, marking a significant advancement in precision healthcare and proactive patient management.
In May 2023, Philips launched Virtual Care Management, a comprehensive portfolio of flexible solutions and services health systems, providers, payers, and employers to motivate and engage with patients from anywhere.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.